The Significance of Aldehyde Dehydrogenase 1 in Cancers

Overview

Journal Int J Mol Sci

Publisher MDPI

Date 2025 Jan 11

PMID 39796106

Authors

Anh L Nguyen

Caroline O B Facey

Bruce M Boman

Affiliations

Soon will be listed here.

Abstract

The goal of this paper is to discuss the role of ALDH isozymes in different cancers, review advances in ALDH1-targeting cancer therapies, and explore a mechanism that explains how ALDH expression becomes elevated during cancer development. ALDH is often overexpressed in cancer, and each isoform has a unique expression pattern and a distinct role in different cancers. The abnormal expression of ALDHs in different cancer types (breast, colorectal, lung, gastric, cervical, melanoma, prostate, and renal) is presented and correlated with patient prognosis. ALDH plays a significant role in various cellular functions, such as metabolism, oxidative stress response, detoxification, and cellular differentiation. Among the ALDH families, ALDH1 has gained considerable attention as a cancer stem cell (CSC) marker due to its significant role in the maintenance of stemness and the differentiation of stem cells (SCs), along with its involvement in tumorigenesis. A description of the cellular mechanisms and physiology of ALDH1 that underlies cancer development is provided. Moreover, current advances in ALDH1-targeting cancer therapies are discussed.

References

Moreb J . Aldehyde dehydrogenase as a marker for stem cells. Curr Stem Cell Res Ther. 2008; 3(4):237-46. DOI: 10.2174/157488808786734006. View

Duan X, Hu H, Wang L, Chen L . Aldehyde dehydrogenase 1 family: A potential molecule target for diseases. Cell Biol Int. 2024; . DOI: 10.1002/cbin.12188. View

Xiao Q, Weiner H, Crabb D . The mutation in the mitochondrial aldehyde dehydrogenase (ALDH2) gene responsible for alcohol-induced flushing increases turnover of the enzyme tetramers in a dominant fashion. J Clin Invest. 1996; 98(9):2027-32. PMC: 507646. DOI: 10.1172/JCI119007. View

Venton G, Perez-Alea M, Baier C, Fournet G, Quash G, Labiad Y . Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors. Blood Cancer J. 2016; 6(9):e469. PMC: 5056970. DOI: 10.1038/bcj.2016.78. View

Singh S, Brocker C, Koppaka V, Chen Y, Jackson B, Matsumoto A . Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress. Free Radic Biol Med. 2012; 56:89-101. PMC: 3631350. DOI: 10.1016/j.freeradbiomed.2012.11.010. View

Abourbih S, Sircar K, Tanguay S, Kassouf W, Aprikian A, Mansure J . Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study. World J Surg Oncol. 2013; 11:298. PMC: 3842840. DOI: 10.1186/1477-7819-11-298. View

Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L . Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα. Cell Metab. 2022; 34(9):1312-1324.e6. DOI: 10.1016/j.cmet.2022.08.002. View

Sladek N . Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact. J Biochem Mol Toxicol. 2003; 17(1):7-23. DOI: 10.1002/jbt.10057. View

Sarvi S, Crispin R, Lu Y, Zeng L, Hurley T, Houston D . ALDH1 Bio-activates Nifuroxazide to Eradicate ALDH Melanoma-Initiating Cells. Cell Chem Biol. 2018; 25(12):1456-1469.e6. PMC: 6309505. DOI: 10.1016/j.chembiol.2018.09.005. View

10.

Dinavahi S, Gowda R, Bazewicz C, Battu M, Lin J, Chitren R . Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents. Eur J Med Chem. 2019; 187:111962. DOI: 10.1016/j.ejmech.2019.111962. View

11.

Swain N, Thakur M, Pathak J, Patel S, Hosalkar R . Aldehyde dehydrogenase 1: Its key role in cell physiology and oral carcinogenesis. Dent Med Probl. 2022; 59(4):629-635. DOI: 10.17219/dmp/144575. View

12.

Zhong S, Li L, Zhang Y, Zhang L, Lu J, Guo S . Acetaldehyde dehydrogenase 2 interactions with LDLR and AMPK regulate foam cell formation. J Clin Invest. 2018; 129(1):252-267. PMC: 6307968. DOI: 10.1172/JCI122064. View

13.

Liu X, Wang L, Cui W, Yuan X, Lin L, Cao Q . Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells. Oncotarget. 2016; 7(36):58516-58530. PMC: 5295448. DOI: 10.18632/oncotarget.11305. View

14.

Giraud J, Molina-Castro S, Seeneevassen L, Sifre E, Izotte J, Tiffon C . Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells. Int J Cancer. 2019; 146(8):2255-2267. DOI: 10.1002/ijc.32667. View

15.

Cui B, Luo Y, Tian P, Peng F, Lu J, Yang Y . Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells. J Clin Invest. 2019; 129(3):1030-1046. PMC: 6391112. DOI: 10.1172/JCI121685. View

16.

Biswas A, Han S, Tai Y, Ma W, Coker C, Quinn S . Targeting S100A9-ALDH1A1-Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung Cancer. Cancer Discov. 2022; 12(4):1002-1021. PMC: 8983473. DOI: 10.1158/2159-8290.CD-21-0910. View

17.

Yin H, Gao T, Xie J, Huang Z, Zhang X, Yang F . FUBP1 promotes colorectal cancer stemness and metastasis via DVL1-mediated activation of Wnt/β-catenin signaling. Mol Oncol. 2021; 15(12):3490-3512. PMC: 8637553. DOI: 10.1002/1878-0261.13064. View

18.

Liu Z, Sun Y, Rose J, Chung Y, Hsiao C, Chang W . The first structure of an aldehyde dehydrogenase reveals novel interactions between NAD and the Rossmann fold. Nat Struct Biol. 1997; 4(4):317-26. DOI: 10.1038/nsb0497-317. View

19.

Samson J, Ravindran Menon D, Smith D, Baird E, Kitano T, Gao D . Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes. Chem Biol Interact. 2019; 314:108822. PMC: 6916670. DOI: 10.1016/j.cbi.2019.108822. View

20.

Xia J, Li S, Liu S, Zhang L . Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets. MedComm (2020). 2023; 4(1):e195. PMC: 9842923. DOI: 10.1002/mco2.195. View